Sean Parker’s big push to hack cancer takes aim at tumor ‘tags’

December 1, 2016

The Parker Institute for Cancer Immunotherapy is teaming with the Cancer Research Institute and 30 public and private entities — including biotech giant Genentech Inc., next-generation DNA sequencing startup Personalis Inc. of Menlo Park and the University of California, San Francisco – to detect so-called neoantigens that could point researchers toward specific cancer vaccines.

Visit BIZJOURNALS.COM to view the full article.